| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6062291 | Journal of Allergy and Clinical Immunology | 2016 | 49 Pages |
Abstract
Two months of preseasonal immunotherapy with 3 COPs derived from Bet v 1 at a 50-μg dose showed promising efficacy, small risk for systemic reactions, and immunomodulatory changes in this single-season, dose-finding, phase IIb trial in patients allergic to birch pollen.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
François MD, Gilles MD, Alexander PhD, Frédéric MD, PhD, Lars PhD, Marek MD, Margitta MD, Vincent PhD, Christophe PhD,